Your browser doesn't support javascript.
loading
In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab.
Atanackovic, Djordje; Yousef, Sara; Shorter, Christa; Tantravahi, Srinivas K; Steinbach, Mary; Iglesias, Fiorella; Sborov, Douglas; Radhakrishnan, Sabarinath Venniyil; Chiron, Marielle; Miles, Rodney; Salama, Mohamed; Kröger, Nicolaus; Luetkens, Tim.
Afiliação
  • Atanackovic D; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA. djordje.atanackovic@hci.utah.edu.
  • Yousef S; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Shorter C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tantravahi SK; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Steinbach M; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Iglesias F; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Sborov D; Pediatric Oncology and Hematology, University of Utah, Salt Lake City, UT, USA.
  • Radhakrishnan SV; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Chiron M; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Miles R; Sanofi, Vitry-sur-Seine, Paris, France.
  • Salama M; Department of Pathology, University of Utah, Salt Lake City, UT, USA.
  • Kröger N; Department of Pathology, University of Utah, Salt Lake City, UT, USA.
  • Luetkens T; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Leukemia ; 34(1): 317-321, 2020 01.
Article em En | MEDLINE | ID: mdl-31409922
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Anticorpos Monoclonais / Anticorpos Antineoplásicos / Mieloma Múltiplo / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Anticorpos Monoclonais / Anticorpos Antineoplásicos / Mieloma Múltiplo / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article